Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Public funding is backing a new immunotherapy treatment, but the bulk of any profits will go to a private company. So are taxpayers getting a good deal?

from NYT > Health http://ift.tt/2hNwcaR
via health&fitness